These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 7925585

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 23. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 24. Differential cross-tolerance between analgesia produced by alpha 2-adrenoceptor agonists and receptor subtype selective opioid treatments.
    Paul D, Tran JG.
    Eur J Pharmacol; 1995 Jan 05; 272(1):111-4. PubMed ID: 7713142
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Beta-endorphin-(1-27) antagonizes beta-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice.
    Suh HH, Tseng LF, Li CH.
    Neuropharmacology; 1988 Sep 05; 27(9):957-63. PubMed ID: 2972939
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubié M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL.
    J Neurosci; 1998 Sep 15; 18(18):7285-95. PubMed ID: 9736649
    [Abstract] [Full Text] [Related]

  • 30. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice.
    Bian JT, Bhargava HN.
    Peptides; 1996 Sep 15; 17(8):1415-9. PubMed ID: 8971939
    [Abstract] [Full Text] [Related]

  • 31. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC, West TE, Wise RA.
    Brain Res; 1991 Jun 07; 550(2):205-12. PubMed ID: 1653084
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H, Labuz D, Przewłocki R, Przewłocka B.
    J Pharmacol Exp Ther; 1997 Aug 07; 282(2):977-84. PubMed ID: 9262366
    [Abstract] [Full Text] [Related]

  • 33. The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse.
    Suh HW, Lim JS, Song DK, Kim YH, Tseng LF.
    Neuropeptides; 1994 Aug 07; 27(2):143-9. PubMed ID: 7991069
    [Abstract] [Full Text] [Related]

  • 34. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C, Levine JD.
    Brain Res; 1992 Nov 06; 595(1):32-8. PubMed ID: 1334770
    [Abstract] [Full Text] [Related]

  • 35. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM, White TD, Sawynok J.
    J Pharmacol Exp Ther; 1995 Oct 06; 275(1):84-93. PubMed ID: 7562600
    [Abstract] [Full Text] [Related]

  • 36. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla.
    Rossi GC, Pasternak GW, Bodnar RJ.
    Brain Res; 1994 Nov 28; 665(1):85-93. PubMed ID: 7882023
    [Abstract] [Full Text] [Related]

  • 37. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan 28; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 38. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 28; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 39. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS.
    Eur J Pharmacol; 1996 Oct 24; 314(1-2):27-32. PubMed ID: 8957215
    [Abstract] [Full Text] [Related]

  • 40. Dexamethasone-induced selective inhibition of the central mu opioid receptor: functional in vivo and in vitro evidence in rodents.
    Pieretti S, Di Giannuario A, Domenici MR, Sagratella S, Capasso A, Sorrentino L, Loizzo A.
    Br J Pharmacol; 1994 Dec 24; 113(4):1416-22. PubMed ID: 7889299
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.